ALL
-
-
May 25, 2020 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(110 KB)
-
-
May 14, 2020 stock
-
-
stock
-
Announcement about the Adjustment of the Conversion Value for Euro-Yen Denominated Convertible Bonds Maturing in 2023(79 KB)
-
-
May 14, 2020 performance
-
-
performance
-
Summary of Consolidated Financial Results of Fiscal Year Ended March 31, 2020(747 KB)
-
-
Mar 02, 2020 M&A/partnership
-
-
M&A/partnership
-
Announcement of Capital and Business Alliance with Kringle Pharma, Inc.(76 KB)
-
-
Feb 17, 2020 product/service
-
-
product/service
-
Notice Regarding Marketing Approvals for 3 Ingredients / 8 Products of Generic Drugs for KYOSOMIRAI PHARMA(153 KB)
-
-
Feb 14, 2020 stock
-
-
stock
-
Notice of Acquisition Result of Company Stock Through Off-Floor Trading (ToSTNeT-3) for Purchase of Company Stock and Completion of Acquisition of Company Stock(158 KB)
-
-
Feb 13, 2020 stock
-
-
stock
-
Notice of Acquisition of Company Stock and Purchase of Company Stock Through Off-Floor Trading (ToSTNeT-3) for Purchase of Company Stock(168 KB)
-
-
Feb 13, 2020 performance
-
-
performance
-
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2020(344 KB)
-
-
Dec 02, 2019 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(109 KB)
-
-
Nov 27, 2019 other
-
-
other
-
Notice regarding Onsite Inspection at a Consolidated Subsidiary by the Japan Fair Trade Commission(37 KB)
-
-
Nov 07, 2019 performance
-
-
performance
-
Notice Regarding Revision of the Full-year Earnings Forecasts for the Fiscal Year Ending March 2020(86 KB)
-
-
Nov 07, 2019 performance
-
-
performance
-
Summary of Consolidated Financial Results for the First Half of Fiscal Year Ending March 2020(442 KB)
-
-
Oct 30, 2019 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Dosage and Administration of Pitavastatin Calcium Tablets 1mg / 2mg “FFP” for KYOSOMIRAI PHARMA(135 KB)
-
-
Oct 24, 2019 performance
-
-
performance
-
Notice Regarding Revision of the Earnings Forecasts for the First Half of Fiscal Year Ending March 2020(88 KB)
